Kraig Biocraft Laboratories Founder and CEO Kim Thompson has outlined the company’s progress in scaling recombinant spider silk production, focusing on commercial readiness, technological advantages and long-term industry applications. The company is advancing its proprietary platform using
Kraig Biocraft Laboratories, Inc., a global leader in spider silk technology, has secured usage rights to a strategic block of government-owned mulberry gardens located near its spider silk production operations in Southeast Asia, supporting a major expansion of its manufacturing capacity. The land-use rights were granted by a key government agency under Kraig Labs’
Kraig Biocraft Laboratories, Inc., a leading innovator in spider silk-based fibres, has announced the production of over 1,200 pounds of recombinant spider silk cocoons in the past 12 months. This output surpasses the company’s cumulative production from all previous years, marking a major milestone in scaling spider silk for commercial use. The surge in production […]














